Published in Arthritis Rheum on May 01, 2007
Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort. Arthritis Rheum (2009) 1.37
Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study. Arthritis Res Ther (2009) 1.29
Vitamin D deficiency is common and associated with increased C-reactive protein in children and young adults with lupus: an Atherosclerosis Prevention in Pediatric Lupus Erythematosus substudy. Lupus Sci Med (2014) 0.96
Vitamin D status is a determinant of atorvastatin effect on carotid intima medial thickening progression rate in children with lupus: an Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) substudy. Lupus Sci Med (2014) 0.96
Osteoporosis and cardiovascular disease care in systemic lupus erythematosus according to new quality indicators. Semin Arthritis Rheum (2010) 0.93
Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohort. Lupus (2010) 0.92
Association between depression and coronary artery calcification in women with systemic lupus erythematosus. Rheumatology (Oxford) (2009) 0.88
Endothelial progenitor cell dysfunction in rheumatic disease. Nat Rev Rheumatol (2009) 0.88
The effect of mycophenolate mofetil on disease development in the gld.apoE (-/-) mouse model of accelerated atherosclerosis and systemic lupus erythematosus. PLoS One (2013) 0.83
Proximal aortic stiffness is increased in systemic lupus erythematosus activity in children and adolescents. ISRN Pediatr (2013) 0.82
Cardiovascular involvement in autoimmune diseases. Biomed Res Int (2014) 0.82
High-density lipoprotein affects antigen presentation by interfering with lipid raft: a promising anti-atherogenic strategy. Clin Exp Immunol (2010) 0.81
Loxoprofen Sodium, a Non-Selective NSAID, Reduces Atherosclerosis in Mice by Reducing Inflammation. J Clin Biochem Nutr (2010) 0.80
Cardiovascular disease in latin american patients with systemic lupus erythematosus: a cross-sectional study and a systematic review. Autoimmune Dis (2013) 0.80
Drugs to Treat Systemic Lupus Erythematosus: Relationship between Current Use and Cardiovascular Risk Factors. Arch Drug Inf (2008) 0.78
Semiquantified noncalcified coronary plaque in systemic lupus erythematosus. J Rheumatol (2012) 0.78
Nephritis and the risk of acute myocardial infarction in patients with systemic lupus erythematosus. Clin Exp Rheumatol (2010) 0.77
Circulating endothelial progenitor cells are reduced in SLE in the absence of coronary artery calcification. Rheumatol Int (2011) 0.77
The lupus susceptibility locus Sle3 is not sufficient to accelerate atherosclerosis in lupus-susceptible low density lipoprotein receptor-deficient mice. Lupus (2009) 0.77
Coronary calcification in SLE: comparison with the Multi-Ethnic Study of Atherosclerosis. Rheumatology (Oxford) (2015) 0.77
The JUPITER study: statins for the primary prevention of cardiovascular events in patients with inflammatory rheumatic diseases? F1000 Med Rep (2009) 0.76
Metabolic alterations and increased liver mTOR expression precede the development of autoimmune disease in a murine model of lupus erythematosus. PLoS One (2012) 0.76
Down-regulation of nectin-4 inhibits apoptosis in systemic lupus erythematous (SLE) through targeting Bcl-2/Bax pathway. Int J Clin Exp Pathol (2015) 0.75
Resveratrol counters systemic lupus erythematosus-associated atherogenicity by normalizing cholesterol efflux. Exp Biol Med (Maywood) (2016) 0.75
Premature atherosclerosis in systemic lupus erythematosus: comment on the article by Westerweel et al. Arthritis Rheum (2007) 0.75
Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum (2002) 5.12
Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes (2004) 4.24
Long-term follow-up of a randomised controlled trial of azathioprine/methylprednisolone versus cyclophosphamide in patients with proliferative lupus nephritis. Ann Rheum Dis (2011) 2.11
Beta2-glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome. Blood (2010) 2.04
TGF-beta1 induces efficient differentiation of human cardiomyocyte progenitor cells into functional cardiomyocytes in vitro. Stem Cell Res (2008) 1.98
Cellular stress conditions are reflected in the protein and RNA content of endothelial cell-derived exosomes. J Extracell Vesicles (2012) 1.81
Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis. Arthritis Rheum (2007) 1.69
Rationale and design of the JUVENTAS trial for repeated intra-arterial infusion of autologous bone marrow-derived mononuclear cells in patients with critical limb ischemia. J Vasc Surg (2010) 1.60
Sympathetic hyperactivity in hypertensive chronic kidney disease patients is reduced during standard treatment. Hypertension (2007) 1.59
Sympathetic hyperactivity in haemodialysis patients is reduced by short daily haemodialysis. J Hypertens (2007) 1.56
DNA replication stress underlies renal phenotypes in CEP290-associated Joubert syndrome. J Clin Invest (2015) 1.55
Prevalence of atherosclerotic renal artery stenosis in patients starting dialysis. Nephrol Dial Transplant (2003) 1.54
Endothelial cells require miR-214 to secrete exosomes that suppress senescence and induce angiogenesis in human and mouse endothelial cells. Blood (2013) 1.51
Chronic kidney disease after myeloablative allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant (2007) 1.50
Lgr5(+ve) stem/progenitor cells contribute to nephron formation during kidney development. Cell Rep (2012) 1.49
Prediction rule for cardiovascular events and mortality in peripheral arterial disease patients: data from the prospective Second Manifestations of ARTerial disease (SMART) cohort study. J Vasc Surg (2009) 1.43
Sympathetic hyperactivity in chronic kidney disease: pathogenesis, clinical relevance, and treatment. Kidney Int (2004) 1.40
Exosomes and the kidney: prospects for diagnosis and therapy of renal diseases. Kidney Int (2011) 1.37
Human embryonic mesenchymal stem cell-derived conditioned medium rescues kidney function in rats with established chronic kidney disease. PLoS One (2012) 1.36
Tetrahydrobiopterin, but not L-arginine, decreases NO synthase uncoupling in cells expressing high levels of endothelial NO synthase. Hypertension (2005) 1.29
Pathogenic anti-beta2-glycoprotein I antibodies recognize domain I of beta2-glycoprotein I only after a conformational change. Blood (2005) 1.29
Bone-marrow-derived cells contribute to glomerular endothelial repair in experimental glomerulonephritis. Am J Pathol (2003) 1.28
Different effects of tacrolimus and cyclosporine on renal hemodynamics and blood pressure in healthy subjects. Transplantation (2002) 1.25
Causes and consequences of increased sympathetic activity in renal disease. Hypertension (2004) 1.24
Understanding eNOS for pharmacological modulation of endothelial function: a translational view. Curr Pharm Des (2007) 1.24
beta2-glycoprotein I-dependent lupus anticoagulant highly correlates with thrombosis in the antiphospholipid syndrome. Blood (2004) 1.23
Dimers of beta 2-glycoprotein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2'. J Biol Chem (2003) 1.20
In mice, proteinuria and renal inflammatory responses to albumin overload are strain-dependent. Nephrol Dial Transplant (2005) 1.20
IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis. Blood (2004) 1.19
Apolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome. Blood (2010) 1.15
Interobserver agreement of scoring of histopathological characteristics and classification of lupus nephritis. Nephrol Dial Transplant (2007) 1.13
End-stage renal disease causes an imbalance between endothelial and smooth muscle progenitor cells. Am J Physiol Renal Physiol (2007) 1.09
Progenitor cells and vascular function are impaired in patients with chronic kidney disease. Nephrol Dial Transplant (2010) 1.09
Sympathetic nerve activity is inappropriately increased in chronic renal disease. J Am Soc Nephrol (2003) 1.08
Maternal supplementation with citrulline increases renal nitric oxide in young spontaneously hypertensive rats and has long-term antihypertensive effects. Hypertension (2007) 1.07
The use of endothelial progenitor cells for prevascularized bone tissue engineering. Tissue Eng Part A (2009) 1.07
Progenitor cell therapy in patients with critical limb ischemia without surgical options. Ann Surg (2008) 1.05
Loss of endogenous bone morphogenetic protein-6 aggravates renal fibrosis. Am J Pathol (2011) 1.03
Correlation between antiphospholipid antibodies that recognize domain I of beta2-glycoprotein I and a reduction in the anticoagulant activity of annexin A5. Blood (2006) 1.02
Haematopoietic and endothelial progenitor cells are deficient in quiescent systemic lupus erythematosus. Ann Rheum Dis (2007) 1.02
Perinatal L-arginine and antioxidant supplements reduce adult blood pressure in spontaneously hypertensive rats. Hypertension (2004) 1.02
Resistance to oxidative stress by chronic infusion of angiotensin II in mouse kidney is not mediated by the AT2 receptor. Am J Physiol Renal Physiol (2005) 1.01
Autologous bone marrow-derived cell therapy in patients with critical limb ischemia: a meta-analysis of randomized controlled clinical trials. Ann Surg (2013) 1.01
Enalapril and losartan reduce sympathetic hyperactivity in patients with chronic renal failure. J Am Soc Nephrol (2003) 1.00
Target organ cross talk in cardiorenal syndrome: animal models. Am J Physiol Renal Physiol (2012) 0.99
Contribution of volume overload and angiotensin II to the increased pulse wave velocity of hemodialysis patients. J Am Soc Nephrol (2002) 0.99
Quality of life in patients with no-option critical limb ischemia underlines the need for new effective treatment. J Vasc Surg (2010) 0.99
Bone marrow alterations and lower endothelial progenitor cell numbers in critical limb ischemia patients. PLoS One (2013) 0.98
Impaired endothelial progenitor cell mobilization and dysfunctional bone marrow stroma in diabetes mellitus. PLoS One (2013) 0.97
Bone-marrow-derived cells contribute to endothelial repair after thrombotic microangiopathy. Blood (2002) 0.97
Healthy bone marrow cells reduce progression of kidney failure better than CKD bone marrow cells in rats with established chronic kidney disease. Cell Transplant (2012) 0.97
Insights into mechanisms behind arteriogenesis: what does the future hold? J Leukoc Biol (2008) 0.97
Ligation of signal inhibitory receptor on leukocytes-1 suppresses the release of neutrophil extracellular traps in systemic lupus erythematosus. PLoS One (2013) 0.97
Erythropoietin and the cardiorenal syndrome: cellular mechanisms on the cardiorenal connectors. Am J Physiol Renal Physiol (2006) 0.96
Human adipocyte extracellular vesicles in reciprocal signaling between adipocytes and macrophages. Obesity (Silver Spring) (2014) 0.94
Review article: endothelial progenitor cells in renal disease. Nephrology (Carlton) (2009) 0.94
Endothelial progenitor cell levels in obese men with the metabolic syndrome and the effect of simvastatin monotherapy vs. simvastatin/ezetimibe combination therapy. Eur Heart J (2008) 0.93
A prospective study of anti-chromatin and anti-C1q autoantibodies in patients with proliferative lupus nephritis treated with cyclophosphamide pulses or azathioprine/methylprednisolone. Ann Rheum Dis (2006) 0.93
The antibacterial activity of peptides derived from human beta-2 glycoprotein I is inhibited by protein H and M1 protein from Streptococcus pyogenes. Mol Microbiol (2007) 0.93
Coronary collateral circulation: the effects of smoking and alcohol. Atherosclerosis (2006) 0.92
The binding site in {beta}2-glycoprotein I for ApoER2' on platelets is located in domain V. J Biol Chem (2005) 0.92
Broadly altered gene expression in blood leukocytes in essential hypertension is absent during treatment. Hypertension (2004) 0.92
CD34+ cells home, proliferate, and participate in capillary formation, and in combination with CD34- cells enhance tube formation in a 3-dimensional matrix. Arterioscler Thromb Vasc Biol (2005) 0.90
Psychological and somatic predictors of perceived and measured ocular dryness of patients with primary Sjögren's syndrome. J Rheumatol (2005) 0.89
Circulating endothelial progenitor cell levels are higher during childhood than in adult life. Atherosclerosis (2008) 0.88
Hypertriglyceridemia in patients with chronic renal failure: possible mechanisms. Kidney Int Suppl (2003) 0.88
Association between beta2-glycoprotein I plasma levels and the risk of myocardial infarction in older men. Blood (2009) 0.88
Endothelial progenitor cell dysfunction in rheumatic disease. Nat Rev Rheumatol (2009) 0.88
Newer drugs for the treatment of lupus nephritis. Drugs (2003) 0.88
Hypercholesterolemia in rats induces podocyte stress and decreases renal cortical nitric oxide synthesis via an angiotensin II type 1 receptor-sensitive mechanism. J Am Soc Nephrol (2004) 0.88
Moxonidine normalizes sympathetic hyperactivity in patients with eprosartan-treated chronic renal failure. J Am Soc Nephrol (2004) 0.88
Central hemodynamics of hypertensive disorders in pregnancy. Am J Hypertens (2004) 0.88
Erythropoietin treatment in patients with combined heart and renal failure: objectives and design of the EPOCARES study. J Nephrol (2010) 0.87
beta2-glycoprotein I, the playmaker of the antiphospholipid syndrome. Clin Immunol (2004) 0.87
Nitric oxide donor induces temporal and dose-dependent reduction of gene expression in human endothelial cells. Am J Physiol Heart Circ Physiol (2004) 0.87
Deposition of nucleosomal antigens (histones and DNA) in the epidermal basement membrane in human lupus nephritis. Arthritis Rheum (2003) 0.87
RANTES is required for ischaemia-induced angiogenesis, which may hamper RANTES-targeted anti-atherosclerotic therapy. Thromb Haemost (2008) 0.87
Validation and use of the Finometer for blood pressure measurement in normal, hypertensive and pre-eclamptic pregnancy. J Hypertens (2003) 0.87
Effects of endothelin-1 and endothelin-1 receptor blockade on cardiac output, aortic pressure, and pulse wave velocity in humans. Hypertension (2003) 0.87
Proteinuria is preceded by decreased nitric oxide synthesis and prevented by a NO donor in cholesterol-fed rats. Kidney Int (2002) 0.86
Programming blood pressure in adult SHR by shifting perinatal balance of NO and reactive oxygen species toward NO: the inverted Barker phenomenon. Am J Physiol Renal Physiol (2004) 0.86
Transcriptome analysis in endothelial progenitor cell biology. Antioxid Redox Signal (2011) 0.86
Folic acid supplementation normalizes the endothelial progenitor cell transcriptome of patients with type 1 diabetes: a case-control pilot study. Cardiovasc Diabetol (2009) 0.85
The use of glucocorticoids in systemic lupus erythematosus. After 60 years still more an art than science. Autoimmun Rev (2012) 0.85
Male gender increases sensitivity to renal injury in response to cholesterol loading. Am J Physiol Renal Physiol (2002) 0.84
Hemodialysis acutely impairs endothelial function in children. Pediatr Nephrol (2004) 0.84
Endothelial progenitor cells: mainly derived from the monocyte/macrophage-containing CD34- mononuclear cell population and only in part from the hematopoietic stem cell-containing CD34+ mononuclear cell population. Circulation (2003) 0.84
Cortisol during the day in patients with systemic lupus erythematosus or primary Sjogren's syndrome. J Rheumatol (2010) 0.83
The nitric oxide donor molsidomine rescues cardiac function in rats with chronic kidney disease and cardiac dysfunction. Am J Physiol Heart Circ Physiol (2010) 0.83
Role of circulating karyocytes in the initiation and progression of atherosclerosis. Hypertension (2006) 0.83
Arterial stiffness and fetal growth in normotensive pregnancy. Am J Hypertens (2005) 0.83
Antiphospholipid antibodies: update on detection, pathophysiology, and treatment. Curr Opin Hematol (2004) 0.83